Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | F7 | P08709 | 4/20 | 0.61 |
| ▸ | F3 | P13726 | 4/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.61 |
| ▸ | PPARD | Q03181 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | FABP3 | P05413 | 3/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.61 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.61 |
| ▸ | FABP4 | P15090 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3659126 | 0.95 | MGLL (0.61) | ALDH1A1F7F3KDM4EPPARG | |
| SCHEMBL3659122 | 0.95 | MGLL (0.61) | ALDH1A1F7F3KDM4EPPARG | |
| SCHEMBL3660734 | 0.95 | FAAH (0.58) | F7F3PPARGPPARDPPARA | |
| SCHEMBL3660737 | 0.95 | FAAH (0.58) | F7F3PPARGPPARDPPARA | |
| SCHEMBL4263808 | 0.95 | FAAH (0.58) | F7F3PPARGPPARDPPARA | |
| Ammonia Solution, Strong SCHEMBL8661313 | 0.94 | FAAH (0.56) | F7F3PPARGPPARDPPARA | |
| SCHEMBL3663321 | 0.91 | ALDH1A1 (0.68) | ALDH1A1F7F3KDM4EPPARG | |
| SCHEMBL31307952 | 0.88 | HSD17B10 (0.49) | ALDH1A1F7F3PPARGPPARD | |
| SCHEMBL27216395 | 0.87 | MEN1 (0.68) | ALDH1A1KDM4ECYP3A4ALOX15HSD17B10 | |
| SCHEMBL28544722 | 0.87 | FAAH (0.50) | F7F3PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109438240-B | Preparation method of stable iodized linoleate | 季珉 | 2022-05-03 | — | — | CN | claimed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | claimed |
| US-11351265-B2 | Process for formulating an anionic agent | DICERNA PHARMACEUTICALS, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| CN-109438240-B | Preparation method of stable iodized linoleate | 季珉 | 2022-05-03 | — | — | CN | disclosed |
| US-20210292303-A1 | AMINE CATIONIC LIPIDS AND USES THEREOF | DICERNA PHARMACEUTICALS, INC. | 2021-09-23 | — | — | US | disclosed |
| US-11059807-B2 | Amine cationic lipids and uses thereof | DICERNA PHARMACEUTICALS, INC. (US) | 2021-07-13 | — | — | US | disclosed |
| CN-112300032-A | Branched alkyl sulfonate anionic surfactant and preparation process thereof | 太原理工大学 | 2021-02-02 | — | — | CN | disclosed |
| US-20190151461-A1 | PROCESS FOR FORMULATING AN ANIONIC AGENT | DICERNA PHARMACEUTICALS, INC. (US) | 2019-05-23 | — | — | US | disclosed |
| US-20190084965-A1 | AMINE CATIONIC LIPIDS AND USES THEREOF | NOVO NORDISK A/S (DK) | 2019-03-21 | — | — | US | disclosed |
| CN-109438240-A | A kind of preparation method of stable iodinated linoleic acid ester | 季珉 | 2019-03-08 | — | — | CN | disclosed |
| EP-2209547-B1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIV KANSAS (US) | 2018-06-20 | — | — | EP | disclosed |
| US-20140371293-A1 | Amine Cationic Lipids and Uses Thereof | DICERNA PHARMACEUTICALS, INC. (US) | 2014-12-18 | — | — | US | disclosed |
| US-8801939-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2014-08-12 | — | — | US | disclosed |
| US-20130240781-A1 | Ozonolysis Reactions in Liquid CO2 and CO2-Expanded Solvents | ARCHER DANIELS MIDLAND COMPANY (US) | 2013-09-19 | — | — | US | disclosed |
| US-8425784-B2 | Ozonolysis reactions in liquid CO2 and CO2-expanded solvents | UNIVERSITY OF KANSAS (US) | 2013-04-23 | — | — | US | disclosed |
| EP-2209547-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | University Of Kansas (US) | 2010-07-28 | — | — | EP | disclosed |
| WO-2009061806-A2 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | UNIVERSITY OF KANSAS (US) | 2009-05-14 | — | — | WO | disclosed |
| US-20090118498-A1 | OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS | ARCHER DANIELS MIDLAND COMPANY | 2009-05-07 | — | — | US | disclosed |
| US-4364743-A | ESTER AND MIDDLE OIL | ERNER WILLIAM E | 1982-12-21 | — | — | US | disclosed |
| US-3995059-A | CHOLESTEROL LOWERING AGENTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190084965-A1 | AMINE CATIONIC LIPIDS AND USES THEREOF | SGMS2, SLC43A1, SGMS1 | ALDH1A1 4162/4885F7 3527/4885F3 3893/4885 |
| US-11351265-B2 | Process for formulating an anionic agent | PHOSPHO1, POLRMT, LIPA | ALDH1A1 3400/4885F7 1368/4885F3 3520/4885 |
| US-20190151461-A1 | PROCESS FOR FORMULATING AN ANIONIC AGENT | PHOSPHO1, POLRMT, LIPA | ALDH1A1 3400/4885F7 1368/4885F3 3520/4885 |
| US-11059807-B2 | Amine cationic lipids and uses thereof | SGMS2, SLC43A1, SGMS1 | ALDH1A1 4162/4885F7 3527/4885F3 3893/4885 |
| US-20140371293-A1 | Amine Cationic Lipids and Uses Thereof | SGMS2, SLC43A1, SGMS1 | ALDH1A1 4162/4885F7 3527/4885F3 3893/4885 |
| US-20210292303-A1 | AMINE CATIONIC LIPIDS AND USES THEREOF | SGMS2, SLC43A1, SGMS1 | ALDH1A1 4162/4885F7 3527/4885F3 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.